<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">3 Biotech</journal-id><journal-id journal-id-type="iso-abbrev">3 Biotech</journal-id><journal-title-group><journal-title>3 Biotech</journal-title></journal-title-group><issn pub-type="epub">2190-5738</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28330327</article-id><article-id pub-id-type="pmc">5135703</article-id><article-id pub-id-type="publisher-id">572</article-id><article-id pub-id-type="doi">10.1007/s13205-016-0572-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Role of <italic>GNB3</italic>, <italic>NET</italic>, <italic>KCNJ11</italic>, <italic>TCF7L2</italic> and <italic>GRL</italic> genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rizvi</surname><given-names>Saliha</given-names></name><address><email>rizvi_saliha@rediffmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Raza</surname><given-names>Syed Tasleem</given-names></name><address><phone>+91 522 2408122</phone><phone>+91 522 2408123</phone><email>tasleem24@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rahman</surname><given-names>Qamar</given-names></name><address><email>drqamar15@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mahdi</surname><given-names>Farzana</given-names></name><address><email>farzana.mahdi@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Biochemistry, Era&#x02019;s Lucknow Medical College and Hospital, Lucknow, 226003 India </aff><aff id="Aff2"><label>2</label>Amity University, Lucknow Campus, Lucknow, Uttar Pradesh India </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2016</year></pub-date><volume>6</volume><issue>2</issue><elocation-id>255</elocation-id><history><date date-type="received"><day>3</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p>Type 2 diabetes (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion or insulin resistance. Various environmental and genetic factors interact and increase the risk of T2DM and its complications. Among the various genetic factors associated with T2DM, single nucleotide polymorphism in different candidate genes have been studied intensively and the resulting genetic variants have been found to have either positive or negative association with T2DM thereby increasing or decreasing the risk of T2DM, respectively. In this review, we will focus on <italic>Guanine nucleotide</italic>-<italic>binding protein subunit beta 3 (GNB3), Norepinephrine Transporter (NET), Potassium Channel gene (KCNJ11), Transcription Factor 7</italic>-<italic>Like 2 (TCF7L2) and Glucocorticoid receptor (GRL)</italic> genes and their association with T2DM studied in different ethnic groups. The products of these genes are involved in the biochemical pathway leading to T2DM. Polymorphisms in these genes have been intensively studied in individuals of different ethnic origins. Results show that genetic variants of <italic>TCF7L2</italic> and <italic>KCNJ11</italic> genes have potential to emerge as a risk biomarker for T2DM whereas results of <italic>GNB3</italic>, <italic>GRL</italic> and <italic>NET</italic> genes have been controversial when studied in individuals of different ethnicities. We have tried to summarize the results generated globally in context to the selected genes which could possibly help researchers working in this field and would eventually help in understanding the mechanistic pathways of T2DM leading early diagnosis and prevention.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Genetic polymorphism</kwd><kwd><italic>GNB3</italic></kwd><kwd><italic>GRL</italic></kwd><kwd><italic>NET</italic></kwd><kwd><italic>KCNJ11</italic></kwd><kwd><italic>TCF7L2</italic></kwd><kwd>Type 2 diabetes mellitus</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; King Abdulaziz City for Science and Technology 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Diabetes mellitus is a widely recognized major health issues affecting more than 170&#x000a0;million individuals worldwide. Among the different types of diabetes i.e., type 1 diabetes, type 2 diabetes and gestational diabetes, majority of diabetes cases (~90%) are of type 2 diabetes mellitus (T2DM). Increase in incidences of T2DM is becoming a major concern in developing countries and has emerged as an epidemic worldwide. It is predicted that by 2030 India will harbour 79.4 diabetics followed by China (42.3&#x000a0;million) and the United States (30.3&#x000a0;million) (Kaveeshwar and Cornwall <xref ref-type="bibr" rid="CR40">2014</xref>). It is characterized by hyperglycemia occurring as a result of impaired insulin secretion, insulin resistance and increased glucose output by liver or a combination of them (American Diabetes Association <xref ref-type="bibr" rid="CR5">2004</xref>). Long standing T2DM increases the risk of associated micro and macro vascular complications such as stroke, dyslipidemia, retinopathy, heart disease, stroke, peripheral neuropathy, nephropathy (Rizvi et al. <xref ref-type="bibr" rid="CR66">2014</xref>), blindness and amputation (Brownlee <xref ref-type="bibr" rid="CR11">2001</xref>). Various factors and their combined effects have been found to contribute to the development of T2DM such as environmental factors, obesity, lifestyle, family history, drugs, etc. Apart from these factors T2DM have a strong genetic component since it&#x02019;s a polygenic disease with multiple genes interacting with one another along with other factors especially with various environmental factors contributing to disease susceptibility (Jenkins et al. <xref ref-type="bibr" rid="CR38">2013</xref>).</p><p>Over the past few decades variants in various candidate genes for T2DM such as <italic>KCNJ11</italic> (Gloyn et al. <xref ref-type="bibr" rid="CR29">2003</xref>), <italic>TCF7L2</italic> (Grant et al. <xref ref-type="bibr" rid="CR30">2006</xref>), <italic>PPAR</italic>-<italic>G</italic> (Altshuler et al. <xref ref-type="bibr" rid="CR4">2000</xref>)<italic>, CAPN10</italic> (Tsuchiya et al. <xref ref-type="bibr" rid="CR82">2006</xref>), <italic>GSTT1/M1</italic> (Raza et al. <xref ref-type="bibr" rid="CR65">2014</xref>), <italic>FTO</italic> (Raza et al. <xref ref-type="bibr" rid="CR65">2014</xref>), <italic>PTPNI</italic> (Florez et al. <xref ref-type="bibr" rid="CR24">2005</xref>), etc. have been extensively studied and investigated through genetic linkage analysis and association studies to find their possible association with T2DM and declare them as susceptible genes. Most of the susceptibility genes were found to perform key regulatory functions in various pathways leading to glucose tolerance thus resulting in disease outcome (Lorenzo et al. <xref ref-type="bibr" rid="CR48">2013</xref>).</p><p>Identification of susceptibility genes is an important area of diabetes research since it help in finding genetic biomarkers which could help in early identification, treatment, and thus prevention of disease in susceptible individuals. Early identification and subsequent treatment strategies would also prevent the risk of developing the risk of secondary complication associated with T2DM in the susceptible individuals. However, these genetic biomarkers interact with various environmental and lifestyle factors to predispose an individual to T2DM risk. Since these environmental and lifestyle factors change with each ethnic group, a gene which shows association with T2DM in one ethnic group might show weak or no association in a different ethnic group. Thus, it is important to replicate the association studies and identify as well as characterize the gene variants related to T2DM in each ethnic group (Yamada et al. <xref ref-type="bibr" rid="CR87">2006</xref>).</p></sec><sec id="Sec2"><title>Candidate and susceptibility genes for T2DM</title><p>The candidate gene approach in T2DM research helps in the identification of those genetic variants which are associated with disease outcome. Meta-analysis studies conducted worldwide on various candidate genes help in the determination of susceptibility genes for a particular disease. However, in case of a polygenic disease the results may not be conclusive since gene&#x02013;gene interactions also play an important role since the contribution of a gene variant is more profound for a disease phenotype when it is the result of gene&#x02013;gene interactions. A large number of candidate genes have been studied in the last two decades and enormous data is available from various association studies conducted on a global scale. In this review, we will focus on <italic>GNB3</italic>, <italic>NET</italic>, <italic>KCNJ11</italic>, <italic>TCF7L2</italic> and <italic>GRL</italic> genes and their association with T2DM studied in different ethnic groups as shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The products of these genes are involved in the biochemical pathway leading to T2DM. Products of <italic>GNB3</italic> gene regulate blood glucose levels through metabolic pathway of insulin signaling, while that of <italic>NET</italic> gene is involved in sodium&#x02013;chloride dependent active reuptake of norepinephrine which in turn increases release of glucagon from pancreas thereby increasing blood glucose levels. <italic>KCNJ11</italic> gene product was found to regulate insulin secretion; <italic>TCF7L2</italic> is involved in survival and functioning of beta cells (Shu et al. <xref ref-type="bibr" rid="CR76">2008</xref>) and insulin secretion, while <italic>GRL</italic> plays role in beta cell function. Polymorphisms in these genes have been intensively studied in individuals of different ethnic origins. Results show that genetic variants of <italic>TCF7L2</italic> and <italic>KCNJ11</italic> genes have potential to emerge as a risk biomarker for T2DM, whereas results of <italic>GNB3</italic>, <italic>GRL</italic> and <italic>NET</italic> genes have been controversial when studied in individuals of different ethnicities.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Significance of <italic>GNB3</italic>, <italic>NET</italic>, <italic>KCNJ11</italic>, <italic>TCF7L2</italic> and <italic>GRL</italic> genes polymorphism with T2DM in various ethnic groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">S. no.</th><th align="left">Gene</th><th align="left">Polymorphism</th><th align="left">Ethnicity</th><th align="left">Case/control (<italic>n</italic>)</th><th align="left">Significance</th><th align="left">References</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">
<italic>GNB</italic>
</td><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Arab</td><td align="left">256/254</td><td align="left">Y</td><td align="left">Kiani et al. (<xref ref-type="bibr" rid="CR42">2005</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Caucasian</td><td align="left">1358/4723</td><td align="left">Y</td><td align="left">Andersen et al. (<xref ref-type="bibr" rid="CR7">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Japanese</td><td align="left">472/388</td><td align="left">Y</td><td align="left">Hayakawa et al. (<xref ref-type="bibr" rid="CR35">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Japanese</td><td align="left">230/2576</td><td align="left">Y</td><td align="left">Daimon et al. (<xref ref-type="bibr" rid="CR20">2008</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Asian Indian</td><td align="left">576</td><td align="left">Y</td><td align="left">Pemberton et al. (<xref ref-type="bibr" rid="CR61">2008</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Hispanic American population</td><td align="left">185/261</td><td align="left">N</td><td align="left">Parra et al. (<xref ref-type="bibr" rid="CR60">2004</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Danish</td><td align="left">4387/3131</td><td align="left">N</td><td align="left">Andersen et al. (<xref ref-type="bibr" rid="CR7">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">South Indians</td><td align="left">70/70</td><td align="left">N</td><td align="left">Chandrasekaran et al. (<xref ref-type="bibr" rid="CR15">2012</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Canadian</td><td align="left">522</td><td align="left">Y</td><td align="left">Pollex et al. (<xref ref-type="bibr" rid="CR62">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>C825T (rs 5443)</italic>
</td><td align="left">Greek</td><td align="left">226/110</td><td align="left">N</td><td align="left">Maniotis et al. (<xref ref-type="bibr" rid="CR50">2014</xref>)</td></tr><tr><td align="left">2</td><td align="left">
<italic>NET</italic>
</td><td align="left">
<italic>G1287</italic>
</td><td align="left">Caucasians</td><td align="left">310/360</td><td align="left">N</td><td align="left">Ksiazek et al. (<xref ref-type="bibr" rid="CR45">2006</xref>)</td></tr><tr><td align="left">3</td><td align="left">
<italic>KCNJ11</italic>
</td><td align="left">
<italic>E23K (rs5219)</italic>
</td><td align="left">Chinese Han population</td><td align="left">502/252</td><td align="left">Y</td><td align="left">Liu et al. (<xref ref-type="bibr" rid="CR47">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5210</italic>
</td><td align="left">Chinese Han population</td><td align="left">502/252</td><td align="left">Y</td><td align="left">Liu et al. (<xref ref-type="bibr" rid="CR47">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5210</italic>
</td><td align="left">Korean</td><td align="left">761/630</td><td align="left">Y</td><td align="left">Koo et al. (<xref ref-type="bibr" rid="CR44">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5215</italic>
</td><td align="left">Chinese Han population</td><td align="left">502/252</td><td align="left">Y</td><td align="left">Liu et al. (<xref ref-type="bibr" rid="CR47">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5215</italic>
</td><td align="left">North Indians</td><td align="left">1019/1006</td><td align="left">Y</td><td align="left">Chavali et al. (<xref ref-type="bibr" rid="CR17">2011</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5215</italic>
</td><td align="left">Japanese</td><td align="left">909/893</td><td align="left">Y</td><td align="left">Sakamoto et al. (<xref ref-type="bibr" rid="CR69">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs5219</italic>
</td><td align="left">Mauritanian</td><td align="left">135/135</td><td align="left">Y</td><td align="left">Abdelhamid et al. (<xref ref-type="bibr" rid="CR1">2014</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">Chinese and East Asian</td><td align="left">1912/2041</td><td align="left">Y</td><td align="left">Zhou et al. (<xref ref-type="bibr" rid="CR90">2009</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs886288</italic>
</td><td align="left">Korean</td><td align="left">761/630</td><td align="left">Y</td><td align="left">Koo et al. (<xref ref-type="bibr" rid="CR44">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372</italic> and <italic>rs7903146</italic>
</td><td align="left">Finnish</td><td align="left">1151/953</td><td align="left">Y</td><td align="left">Scott et al. (<xref ref-type="bibr" rid="CR72">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7901695 rs7903146</italic>
</td><td align="left">Amish</td><td align="left">276/342</td><td align="left">Y</td><td align="left">Damcott et al. (<xref ref-type="bibr" rid="CR21">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7901695</italic> and <italic>rs7903146</italic>
</td><td align="left">Amish</td><td align="left">276/342</td><td align="left">Marginal association</td><td align="left">Damcott et al. (<xref ref-type="bibr" rid="CR21">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372</italic>
</td><td align="left">U. S</td><td align="left">687/1051</td><td align="left">Y</td><td align="left">Zhang et al. (<xref ref-type="bibr" rid="CR89">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs11196205</italic>
</td><td align="left">Chinese</td><td align="left">433/419</td><td align="left">Y</td><td align="left">Ng et al. (<xref ref-type="bibr" rid="CR57">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146</italic>
</td><td align="left">Brazilian</td><td align="left">190/370</td><td align="left">Y</td><td align="left">Marquezine et al. (<xref ref-type="bibr" rid="CR51">2008</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372 rs12255372 rs7903146 rs7901695</italic>
</td><td align="left">Japanese</td><td align="left">1630/1064</td><td align="left">Y</td><td align="left">Hayashi et al. (<xref ref-type="bibr" rid="CR36">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372 rs7903146</italic>
</td><td align="left">Dutch</td><td align="left">502/920</td><td align="left">Y</td><td align="left">van Vliet-Ostaptchouk et al. (<xref ref-type="bibr" rid="CR84">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146</italic>
</td><td align="left">Iranian</td><td align="left">258/168</td><td align="left">Y</td><td align="left">Amoli et al. (<xref ref-type="bibr" rid="CR6">2010</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372 rs4506565 rs7903146</italic>
</td><td align="left">Indians</td><td align="left">955/399</td><td align="left">Y</td><td align="left">Chandak et al. (<xref ref-type="bibr" rid="CR14">2007</xref>)</td></tr><tr><td align="left">4</td><td align="left">
<italic>TCF7L2</italic>
</td><td align="left">rs7903146</td><td align="left">Danish</td><td align="left">31/31</td><td align="left">Y</td><td align="left">Gjesing et al. <xref ref-type="bibr" rid="CR28">2011</xref>
</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372</italic>
</td><td align="left">Europeans Caucasians<break/>Asians</td><td align="left">34,076/36,192</td><td align="left">Y</td><td align="left">Wang et al. (<xref ref-type="bibr" rid="CR85">2013</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left">Africans</td><td align="left"/><td align="left">N</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372</italic>
</td><td align="left">Cameroonian</td><td align="left">60/60</td><td align="left">Y</td><td align="left">Nanfa et al. (<xref ref-type="bibr" rid="CR55">2015</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146</italic>
</td><td align="left">Moroccans</td><td align="left">504/406</td><td align="left">Y</td><td align="left">Cauchi et al. (<xref ref-type="bibr" rid="CR13">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146</italic>
</td><td align="left">Austrians</td><td align="left">486/1075</td><td align="left">Y</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs12255372</italic>
</td><td align="left">French</td><td align="left">2367/2499</td><td align="left">Y</td><td align="left">Cauchi et al. (<xref ref-type="bibr" rid="CR12">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs12255372 rs11196205</italic>
</td><td align="left">South Indian</td><td align="left">758/621</td><td align="left">Y</td><td align="left">Jyothi et al. (<xref ref-type="bibr" rid="CR39">2013</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7901695, rs7903146, rs7895340, rs11196205, rs12255372</italic>
</td><td align="left">African Americans</td><td align="left">577/632</td><td align="left">Y</td><td align="left">Sale et al. (<xref ref-type="bibr" rid="CR70">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372 rs7903146</italic>
</td><td align="left">Finnish</td><td align="left">1151/953</td><td align="left">Y</td><td align="left">Scott et al. (<xref ref-type="bibr" rid="CR72">2006</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs11196218</italic>
</td><td align="left">Asian</td><td align="left">1842/4444</td><td align="left">Y</td><td align="left">Zhai et al. (<xref ref-type="bibr" rid="CR88">2014</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs11196205 rs12255372</italic>
</td><td align="left">Japanese</td><td align="left">2214/1873</td><td align="left">Y</td><td align="left">Miyake et al. (<xref ref-type="bibr" rid="CR54">2008</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs290487</italic>
</td><td align="left">Han Chinese</td><td align="left">760/760</td><td align="left">Y</td><td align="left">Chang et al. (<xref ref-type="bibr" rid="CR16">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs12255372</italic>
</td><td align="left">Han Chinese</td><td align="left">760/760</td><td align="left">N</td><td align="left">Chang et al. (<xref ref-type="bibr" rid="CR16">2007</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs7901695 rs12255372</italic>
</td><td align="left">Italian</td><td align="left">154/171</td><td align="left">Y</td><td align="left">Cincia et al. (<xref ref-type="bibr" rid="CR18">2012</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs12255372 rs7903146</italic>
</td><td align="left">Arabs</td><td align="left">522/346</td><td align="left">N</td><td align="left">Alsmadi et al. (<xref ref-type="bibr" rid="CR2">2008a</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>rs7903146 rs12255372 rs290487</italic>
</td><td align="left">Kurdish</td><td align="left">173/173</td><td align="left">Y</td><td align="left">Shokouhi et al. (<xref ref-type="bibr" rid="CR75">2014</xref>)</td></tr><tr><td align="left">5</td><td align="left">
<italic>GRL</italic>
</td><td align="left">
<italic>A1220G; N363S</italic>
</td><td align="left">French Caucasians</td><td align="left">369</td><td align="left">N</td><td align="left">Roussel et al. <xref ref-type="bibr" rid="CR68">2003</xref>
</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>Bcl I</italic>
</td><td align="left">Swedish men</td><td align="left">163</td><td align="left">Y</td><td align="left">Rosmond and Holm <xref ref-type="bibr" rid="CR67">2008</xref>
</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>Tth111I</italic>
</td><td align="left">Swedish men</td><td align="left">163</td><td align="left">N</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>A/G</italic>
</td><td align="left">Swedish men</td><td align="left">163</td><td align="left">N</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>Bcl I</italic>
</td><td align="left">British Caucasian</td><td align="left">56/43</td><td align="left">Y</td><td align="left">Weaver et al. (<xref ref-type="bibr" rid="CR86">1992</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>A3669G</italic>
</td><td align="left">Italians</td><td align="left">61/71</td><td align="left">Y</td><td align="left">Trementino et al. (<xref ref-type="bibr" rid="CR81">2012</xref>)</td></tr><tr><td align="left"/><td align="left"/><td align="left">
<italic>BclI, N363S ER22/23EK</italic>
</td><td align="left">Italians</td><td align="left">61/71</td><td align="left">N</td><td align="left">Trementino et al. (<xref ref-type="bibr" rid="CR81">2012</xref>)</td></tr></tbody></table></table-wrap>
</p><sec id="Sec3"><title>Guanine nucleotide-binding protein subunit beta 3 (GNB3) gene</title><p>G proteins also known as heterotrimeric guanine nucleotide-binding proteins are signaling molecules which are involved in regulating blood glucose levels through metabolic pathway of insulin signaling. They are also involved in the stimulation of secondary messengers such as adenylate cyclase, signaling pathways of epinephrine and glucagon receptors in hepatic, muscle and fat-tissue cells which are the pathophysiological signaling pathways leading to T2DM. These heterotrimeric protein molecules are made up of 3 subunits, alpha (&#x003b1;), beta (&#x003b2;) and gamma (&#x003b3;) (Hurowitz et al. <xref ref-type="bibr" rid="CR37">2000</xref>). These G protein-coupled receptors activate a downstream secondary messenger cascade on binding ligand molecules such as hormones, neurotransmitters, chemokines, local mediators, etc. (Chandrasekaran et al. <xref ref-type="bibr" rid="CR15">2012</xref>). The <italic>GNB3</italic> gene codes for the beta3 subunit of G proteins. Any change in the <italic>GNB3</italic> gene due to any mutation or polymorphism may possibly lead to defects in the G protein encoded by the defective gene. These polymorphic changes have been found to be associated with the development of T2DM as well as its associated secondary complications. In this context, the most studied polymorphism of <italic>GNB3</italic> gene is the C825T polymorphism. The 825T variant of <italic>GNB3</italic> gene occurs when cytosine is replaced with thymine at position 825 in exon 10 in the wild-type gene due to alternative splicing leading to loss of 41 amino acids. The mutant 825T allele was associated with an increased production of G&#x003b2;3s (Andersen et al. <xref ref-type="bibr" rid="CR7">2006</xref>), resulting in enhanced signal transduction by G proteins. Studies found that the <italic>GNB3</italic> C825T variant is a risk factor for hypertension, obesity, metabolic syndrome, atherosclerosis and diabetes (Siffert <xref ref-type="bibr" rid="CR77">2005</xref>). Various studies have confirmed the association of <italic>GNB3</italic> polymorphism with T2DM in different populations. In Japanese population, multiple logistic regression analysis showed a significant association of the genotypes TT&#x000a0;+&#x000a0;TC with T2DM (Daimon et al. <xref ref-type="bibr" rid="CR20">2008</xref>). However, the results have been shown to be controversial in this population where another study on the same population found no significant association (Hayakawa et al. <xref ref-type="bibr" rid="CR35">2007</xref>). A study on Emirati and Canadian population found that 825T variant showed a positive association with T2DM risk (Kiani et al. <xref ref-type="bibr" rid="CR42">2005</xref>; Pollex et al. <xref ref-type="bibr" rid="CR62">2006</xref>). Numerous studies have showed a strong association of <italic>GNB3</italic> polymorphism with the risk of diabetic neuropathy in different ethnic groups (Beige et al. <xref ref-type="bibr" rid="CR8">2000</xref>; Bl&#x000fc;thner et al. <xref ref-type="bibr" rid="CR10">1999</xref>; Zychma et al. <xref ref-type="bibr" rid="CR91">2000</xref>). In contrast, some studies have also showed no association of <italic>GNB3</italic> polymorphism with T2DM in Hispanic American (Parra et al. <xref ref-type="bibr" rid="CR60">2004</xref>), Danish (Andersen et al. <xref ref-type="bibr" rid="CR7">2006</xref>), Greek (Maniotis et al. <xref ref-type="bibr" rid="CR50">2014</xref>) and South Indian Populations (Chandrasekaran et al. <xref ref-type="bibr" rid="CR15">2012</xref>).</p></sec><sec id="Sec4"><title>Norepinephrine transporter (NET) gene</title><p>The norepinephrine transporter (NET), also known as solute carrier family 6 member 2 (SLC6A2) (Pacholczyk et al. <xref ref-type="bibr" rid="CR59">1991</xref>). It is a 617 amino acid multipass monoamine symporter protein encoded by <italic>SLC6A2</italic> gene present on chromosome 16 (Gelernter et al. <xref ref-type="bibr" rid="CR26">1993</xref>). It is involved in sodium&#x02013;chloride dependent active reuptake of norepinephrine, a potent neurotransmitter, at neuronal junctions into the presynaptic nerve terminals. It helps in maintaining norepinephrine homeostasis in our body by regulating its metabolism and turnover rates. A potential decrease in norepinephrine uptake sites due to dysfunctional transporter had been observed in various cardiovascular diseases, such as hypertension, cardiomyopathy as well as in diabetes mellitus (Hahn and Blakely <xref ref-type="bibr" rid="CR34">2002</xref>). This could possibly occur as a result of various mutations and polymorphisms where a single nucleotide changes in the gene neither encoding nor epinephrine transporter may result in a non functional protein. A lot of studies have been conducted globally to find a potential relationship between single nucleotide polymorphism in <italic>NET</italic> gene and various diseases such as psychiatric disorders (Tellioglu and Robertson <xref ref-type="bibr" rid="CR79">2001</xref>), hyperactivity disorder (Kim et al. <xref ref-type="bibr" rid="CR43">2006</xref>), ADHD (Shannon et al. <xref ref-type="bibr" rid="CR74">2000</xref>; Neubauer and Christensen <xref ref-type="bibr" rid="CR56">1976</xref>) orthostatic intolerance (Tellioglu and Robertson <xref ref-type="bibr" rid="CR79">2001</xref>; Shannon et al. <xref ref-type="bibr" rid="CR74">2000</xref>) etc. Neubauer in 1976 first reported that norepinephrine concentration reduces considerably in the cardiovascular system of the diabetic patients but till date an insignificant amount of data is present to provide a potential evidence of the association of <italic>NET</italic> gene polymorphism with T2DM. The first ever study in this field was first carried out in 2006 on the G1287 single nucleotide polymorphism present in exon 9 of <italic>NET</italic> gene and T2DM in Caucasians where no significant association was found between this gene polymorphism and the risk of the development of T2DM and diabetic nephropathy (Ksiazek et al. <xref ref-type="bibr" rid="CR45">2006</xref>). However, it was observed that the AA genotype might contribute to the development of hypertension in these diabetic subjects. The frequency of AA genotype is reported to be higher in diabetic patients suffering from hypertension when compared with normotensive diabetic patients (19 vs. 10%, respectively, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, OR&#x000a0;=&#x000a0;2.21 with 95% CI 1.36&#x02013;3.59) (Ksiazek et al. <xref ref-type="bibr" rid="CR45">2006</xref>). To the best of my knowledge this is the only study conducted so far between <italic>NET</italic> gene polymorphism and T2DM which calls for further association studies and testing of coding region variants of this gene and their functional assessment.</p></sec><sec id="Sec5"><title>Potassium channel (KCNJ11) gene</title><p>The Potassium Channel gene also known as the Potassium inwardly rectifying channel, subfamily J, member 11 potassium channel gene and abbreviated as <italic>KCNJ11</italic> belongs to potassium channel gene family. It is located at 11p15.1 on human chromosome and don&#x02019;t have any intronic sequences (Haghvirdizadeh et al. <xref ref-type="bibr" rid="CR33">2015</xref>). This gene encodes a 390 amino acid protein which is an inward-rectifier potassium ion channel called Kir6.2. The Kir6.2 protein along with another protein SUR1 encoded by the <italic>ABCC8</italic> gene located next to the <italic>KCNJ11</italic> gene forms the KATP channel which modulates insulin production and secretion through glucose metabolism (McTaggart et al. <xref ref-type="bibr" rid="CR53">2010</xref>) and is the target of sulphonylurea drugs used for treating diabetes. Genetic polymorphism in <italic>KCNJ11</italic> gene has been shown to be associated with an increased risk of T2DM. The <italic>KCNJ11</italic> gene variant (Glu23Lys or E23K) where glutamic acid is replaced with lysine at 23rd position in the translated protein had been found to be a potential biomarker for T2DM (Qiu et al. <xref ref-type="bibr" rid="CR63">2014</xref>). This variant replaces the amino acid glutamic acid with the amino acid lysine at position 23 in the protein sequence, written as Glu23Lys or E23K. The lysine carrier having the variant gene were found to have reduced insulin secretion but were less likely to develop T2DM (Florez et al. <xref ref-type="bibr" rid="CR25">2007</xref>). A case control and a meta-analysis on Tunisian and Arab population case-also revealed significant association between <italic>KCNJ11</italic> E23K variant and T2DM (Lasram et al. <xref ref-type="bibr" rid="CR46">2014</xref>). Recent study on Iranian subjects demonstrated that the carriers homozygous for KK genotype of <italic>KCNJ11</italic> gene were susceptible to T2DM (<italic>p</italic> value&#x000a0;=&#x000a0;0.049) and the frequency of K allele was higher in T2DM patients than control subjects (Rastegari et al. <xref ref-type="bibr" rid="CR64">2015</xref>). Another study on arab population showed significant association of the KCNJ11 E23K polymorphism with type 2 diabetes (Alsmadi et al. <xref ref-type="bibr" rid="CR2">2008a</xref>). A meta-analysis which included 48 published studies found a higher disease risk among Caucasians and East Asians carrying the lysine variant but no significant association was found with Indian and other ethnic populations (Qiu et al. <xref ref-type="bibr" rid="CR63">2014</xref>). Studies on Russian and Mauritanian populations also found an association between E23K variant and T2DM (Nikitin et al. <xref ref-type="bibr" rid="CR58">2015</xref>; Abdelhamid et al. <xref ref-type="bibr" rid="CR1">2014</xref>). However, apart from above mentioned studies a contrasting finding was observed in Iranian population where <italic>KCNJ11</italic> E23K polymorphism is not associated with genetic susceptibility to T2DM but it was inferred that it might play a role in the progression of T2DM in obese subjects (Keshavarz et al. <xref ref-type="bibr" rid="CR41">2014</xref>). Similarly no significant association was observed in Moroccan population (Benrahma et al. <xref ref-type="bibr" rid="CR9">2014</xref>). Also, it was shown that patients carrying the lysine variant were more prone to secondary failure to sulphonylurea, T2DM treatment drug leading to higher fasting plasma glucose and glycosylated hemoglobin concentrations (Sesti et al. <xref ref-type="bibr" rid="CR73">2006</xref>).</p></sec><sec id="Sec6"><title>Transcription factor 7-like 2 (TCF7L2) gene</title><p>Transcription factor 7-like 2 (<italic>TCF7L2</italic>) is a 215.9&#x000a0;kb gene located at 10q25 on human chromosome (Duval et al. <xref ref-type="bibr" rid="CR23">2000</xref>). TCF7L2 is a major component of Wnt signaling pathway, which is involved in various cellular growth and developmental processes. TCF7L2 regulates various pathways such as adipogenesis, development of pancreatic islet cells, survival and functioning of beta cells (Shu et al. <xref ref-type="bibr" rid="CR76">2008</xref>). It also plays a major role in insulin secretion by regulating various proteins involved in postprandial insulin secretion such as proglucagon and glucagon-like peptides GLP-1 and GLP-2 at transcriptional level (da Silva Xavier et al. <xref ref-type="bibr" rid="CR19">2009</xref>; Doria et al. <xref ref-type="bibr" rid="CR22">2008</xref>). <italic>TCF7L2</italic> variants are regarded as the strongest genetic risk factors for T2DM, since it increase the disease risk 1.5-fold in heterozygotes and 2.4-fold in homozygotes, contributing to a 21% population risk (Grant et al. <xref ref-type="bibr" rid="CR30">2006</xref>). However, the <italic>TCF7L2</italic> disease risk variants were found to vary among different populations (Guinan <xref ref-type="bibr" rid="CR32">2012</xref>). The most studied polymorphisms in <italic>TCF7L2</italic> gene are rs7903146 of the intron 3 (IVS3C&#x000a0;&#x0003e;&#x000a0;T), rs7901695 of the intron 3 (IVS3T&#x000a0;&#x0003e;&#x000a0;C), rs12255372 of the intron 4 (IVS4G&#x000a0;&#x0003e;&#x000a0;T) and rs11196205 of the intron 4 (IVS4G&#x000a0;&#x0003e;&#x000a0;C). Polymorphism in <italic>TCF7L2</italic> gene disrupts body glucose homeostasis by impairing insulin secretion, glucose turnover and glucose tolerance pathways by directly affecting pancreatic beta cells (Lyssenko et al. <xref ref-type="bibr" rid="CR49">2007</xref>; Schafer et al. <xref ref-type="bibr" rid="CR71">2007</xref>). In another study genetic polymorphism in <italic>TCF7L2</italic> gene (rs7903146) was shown to predispose an individual to the risk of developing T2DM where the presence of TT genotype results in elevated plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide levels (Gjesing et al. <xref ref-type="bibr" rid="CR28">2011</xref>). <italic>TCF7L2</italic> variants have been found to have a positive association with T2DM in French (Cauchi et al. <xref ref-type="bibr" rid="CR12">2006</xref>), African-American (Sale et al. <xref ref-type="bibr" rid="CR70">2007</xref>), Finnish (Scott et al. <xref ref-type="bibr" rid="CR72">2006</xref>), U. K. (Groves et al. <xref ref-type="bibr" rid="CR31">2006</xref>), Japanese (Miyake et al. <xref ref-type="bibr" rid="CR54">2008</xref>), Indian (Chandak et al. <xref ref-type="bibr" rid="CR14">2007</xref>) and Chinese (Chang et al. <xref ref-type="bibr" rid="CR16">2007</xref>) populations. Three <italic>TCF7L2</italic> polymorphisms rs7903146, rs7901695 and rs12255372 were found to be associated with T2DM in Italian population and a strong correlation was found between rs7903146 and cardiovascular autonomic neuropathy in the study subjects (Cincia et al. <xref ref-type="bibr" rid="CR18">2012</xref>). In Kurdish population of Iran the T-allele of rs12255372, rs7903146, and rs290487 polymorphisms of <italic>TCF7L2</italic> were found to be a risk allele for T2DM (Shokouhi et al. <xref ref-type="bibr" rid="CR75">2014</xref>). A large meta-analysis demonstrated significant association between IVS3C&#x000a0;&#x0003e;&#x000a0;T as well as IVS4G&#x000a0;&#x0003e;&#x000a0;T <italic>TCF7L2</italic> gene polymorphisms and T2DM where among IVS3C&#x000a0;&#x0003e;&#x000a0;T polymorphism, TC heterozygotes and TT homozygous variants increased risk of T2MD by 1.4-fold and 2.0-fold, respectively, as compared to wild-type CC homozygotes whereas in case of IVS4G&#x000a0;&#x0003e;&#x000a0;T polymorphism, TG heterozygotes and TT homozygous variants increased risk of T2MD by 1.4-fold and 1.9-fold, respectively, as compared to wild-type GG homozygotes (Tong et al. <xref ref-type="bibr" rid="CR80">2009</xref>). In contrast, no significant association was found between <italic>TCF7L2</italic> variants and T2DM among East Asians and conflicting results have appeared, in various studies on Chinese population (Chang et al. <xref ref-type="bibr" rid="CR57">2007</xref>; Ng et al. <xref ref-type="bibr" rid="CR57">2007</xref>). In Arabs, weak or no association was observed in two polymorphisms of <italic>TCF7L2</italic> gene (rs12255372, rs7903146) with T2DM (Alsmadi et al. <xref ref-type="bibr" rid="CR3">2008b</xref>).</p></sec><sec id="Sec7"><title>Glucocorticoid receptor (GRL) gene</title><p>The glucocorticoid receptor gene (<italic>GRL</italic>) also known as <italic>NR3C1</italic> (nuclear receptor subfamily 3, group C, member 1) gene, is located on chromosome number 5 at 5q31 position in humans. (Marti et al. <xref ref-type="bibr" rid="CR52">2006</xref>) It encodes a 777-amino acid (Glucocorticoid receptor &#x003b1;) or a 742-amino acid (Glucocorticoid receptor &#x003b2;) polypeptide which acts as a receptor for cortisol and glucocorticoids and regulates gene expression of various genes involved in cell development, metabolism and immune responses. The 363S allele of the <italic>N363S</italic> variant present in exon 2 of <italic>GRL</italic> gene was found to be associated with the risk of weight gain/obesity but no evidence was found for an association of this variant with parameters related to hyperglycaemia in French Caucasians with T2DM (Roussel et al. <xref ref-type="bibr" rid="CR68">2003</xref>). In another study on Swedish men, significant increase in fasting glucose and insulin were found over the 5-year follow-up among individuals homozygotes for the BclI allele of <italic>GRL</italic> gene whereas no significant associations were found with Tth111I or A/G polymorphism of <italic>GRL</italic> gene with T2DM (Rosmond and Holm <xref ref-type="bibr" rid="CR67">2008</xref>). Similar results were reported in Italian subjects with Addison&#x02019;s disease where patients carrying GG genotype of BclI polymorphism showed higher glucose levels or glucose intolerance as compared to individuals carrying wild-type CC and heterozygous CG genotype (Giordano et al. <xref ref-type="bibr" rid="CR27">2012</xref>). Another study on British Caucasian obese women showed that Bc1I polymorphism was significantly associated with higher fasting insulin and index of insulin resistance (HOMA) (weaver et al. <xref ref-type="bibr" rid="CR86">1992</xref>). In a different study on Italian patients with Cushing&#x02019;s syndrome the A3669G polymorphism of <italic>GRL</italic> gene was seen to have a protective role where it was found to decrease the risk of developing T2DM (Trementino et al. <xref ref-type="bibr" rid="CR81">2012</xref>). In a cross-sectional cohort study on N363S (rs6195), BclI (rs41423247), ER22/23EK (rs6189/6190), 9b A/G (rs6198) and ThtIIII (rs10052957) polymorphisms in KCNJ11 gene, none of the polymorphisms studied was found to be associated with insulin sensitivity, however, <italic>N363S</italic> and <italic>ER22/23EK</italic> polymorphisms of the <italic>GRL</italic> gene were found to be negatively associated with &#x003b2;-cell function in women, but not in men (van Raalte et al. <xref ref-type="bibr" rid="CR83">2012</xref>).</p></sec></sec><sec id="Sec8"><title>Conclusion</title><p>The incidence of diabetes occurrence is increasing at a fast pace globally and present data demonstrate that its prevalence is also increasing among children and adolescents who are below 30&#x000a0;years of age. This calls for an urgent development of techniques and methods to combat this growing epidemic and to identify high-risk individuals at an early stage that could thus be prevented from T2DM by taking suitable preventive measures. Apart from environmental factors such as diet, ethnicity, family history, lifestyle, etc., genetic factors also have a profound effect on the occurrence of T2DM and they interact with the environmental factors in predisposing an individual to T2DM. Thus, a susceptible gene in one population might not show the same phenotypic effect in other population. Various genetic linkage and associations studies have identified several candidate genes for T2DM and ongoing studies on in this field are focusing on identifying novel gene variants which are having a potential role in the pathophysiology of T2DM. This review had summarized the results from various global studies on the association of <italic>GNB3</italic>, <italic>NET</italic>, <italic>KCNJ11</italic>, <italic>TCF7L2</italic> and <italic>GRL</italic> genes with T2DM which could possibly help researchers working in this field and would eventually help in understanding the mechanistic pathways of T2DM. Results show that genetic variants of <italic>TCF7L2</italic> and <italic>KCNJ11</italic> genes have potential to emerge as a risk biomarker for T2DM whereas polymorphisms in <italic>GNB3</italic>, <italic>GRL</italic> and <italic>NET</italic> genes may confer smaller or modifier effects since the results have been controversial and will require further larger studies to fully elucidate their role in T2DM. Thus, we could say that a proper understanding of genetic background of T2DM will help in understanding the biochemical and molecular mechanisms, developing potential biomarkers which could identify at-risk patients in early stages and designing new therapeutics which will thus help in diagnostics, treatment and eventually prevention of this disease.</p></sec></body><back><ack><title>Acknowledgements</title><p>We are thankful for the support received from Era&#x02019;s Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India.</p></ack><notes notes-type="COI-statement"><title>Compliance with ethical standards</title><sec id="FPar1"><title>Conflict of interest</title><p>The authors declare that they have no conflict of interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelhamid</surname><given-names>I</given-names></name><name><surname>Lasram</surname><given-names>K</given-names></name><name><surname>Meiloud</surname><given-names>G</given-names></name><name><surname>Ben Halim</surname><given-names>N</given-names></name><name><surname>Kefi</surname><given-names>R</given-names></name><name><surname>Samb</surname><given-names>A</given-names></name><etal/></person-group><article-title>E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population</article-title><source>Prim Care Diabet</source><year>2014</year><volume>8</volume><issue>2</issue><fpage>171</fpage><lpage>175</lpage></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsmadi</surname><given-names>O</given-names></name><name><surname>Al-Rubeaan</surname><given-names>K</given-names></name><name><surname>Mohamed</surname><given-names>G</given-names></name><name><surname>Alkayal</surname><given-names>F</given-names></name><name><surname>Al-Saud</surname><given-names>H</given-names></name><name><surname>Al-Saud</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Weak or no association of TCF7L2 variants with type 2 diabetes risk in an Arab population</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>72</fpage><pub-id pub-id-type="pmid">18655717</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsmadi</surname><given-names>O</given-names></name><name><surname>Al-Rubeaan</surname><given-names>K</given-names></name><name><surname>Wakil</surname><given-names>SM</given-names></name><name><surname>Imtiaz</surname><given-names>F</given-names></name><name><surname>Mohamed</surname><given-names>G</given-names></name><name><surname>Al-Saud</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes</article-title><source>Diabet Metab Res Rev</source><year>2008</year><volume>24</volume><issue>2</issue><fpage>137</fpage><lpage>140</lpage></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Klannemark</surname><given-names>M</given-names></name><name><surname>Lindgrea</surname><given-names>CM</given-names></name><name><surname>Vohl</surname><given-names>MC</given-names></name><name><surname>Nemesh</surname><given-names>J</given-names></name><etal/></person-group><article-title>The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10973253</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Diagnosis and classification of diabetes mellitus</article-title><source>Diabet Care</source><year>2004</year><volume>1</volume><fpage>S5</fpage><lpage>S10</lpage></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoli</surname><given-names>MM</given-names></name><name><surname>Amiri</surname><given-names>P</given-names></name><name><surname>Tavakkoly-Bazzaz</surname><given-names>J</given-names></name><name><surname>Charmchi</surname><given-names>E</given-names></name><name><surname>Hafeziyeh</surname><given-names>J</given-names></name><etal/></person-group><article-title>Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population</article-title><source>Genet Mol Biol</source><year>2010</year><volume>33</volume><fpage>449</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">21637413</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>G</given-names></name><name><surname>Overgaard</surname><given-names>J</given-names></name><name><surname>Albrechtsen</surname><given-names>A</given-names></name><name><surname>Gl&#x000fc;mer</surname><given-names>C</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Studies of the association of the GNB3 825C&#x0003e; T polymorphism with components of the metabolic syndrome in white Danes</article-title><source>Diabetologia</source><year>2006</year><volume>49</volume><issue>1</issue><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">16284746</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beige</surname><given-names>J</given-names></name><name><surname>Ringel</surname><given-names>J</given-names></name><name><surname>Distler</surname><given-names>A</given-names></name><etal/></person-group><article-title>G-protein &#x003b2;3-subunit C825T genotype and nephropathy in diabetes mellitus</article-title><source>Nephrol Dial Transplant</source><year>2000</year><volume>15</volume><fpage>1384</fpage><lpage>1387</lpage><pub-id pub-id-type="pmid">10978395</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benrahma</surname><given-names>H</given-names></name><name><surname>Charoute</surname><given-names>H</given-names></name><name><surname>Lasram</surname><given-names>K</given-names></name><name><surname>Boulouiz</surname><given-names>R</given-names></name><name><surname>Atig</surname><given-names>RK</given-names></name><name><surname>Fakiri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association Analysis of IGF2BP2, KCNJ11, and CDKAL1 Polymorphisms with Type 2 Diabetes Mellitus in a Moroccan Population: A Case&#x02013;Control Study and Meta-analysis</article-title><source>Biochem Genet</source><year>2014</year><volume>52</volume><issue>9&#x02013;10</issue><fpage>430</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">24898818</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bl&#x000fc;thner</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Siffert</surname><given-names>W</given-names></name><etal/></person-group><article-title>Increased frequency of G-protein &#x003b2;3-subunit 825 T allele in dialyzed patients with type 2 diabetes</article-title><source>Kidney Int</source><year>1999</year><volume>55</volume><fpage>1247</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">10200987</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Biochemistry and molecular cell biology of diabetic complications</article-title><source>Nature</source><year>2001</year><volume>414</volume><fpage>813</fpage><lpage>820</lpage><pub-id pub-id-type="pmid">11742414</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Samson</surname><given-names>C</given-names></name><name><surname>Gallina</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><issue>10</issue><fpage>2903</fpage><lpage>2908</lpage><pub-id pub-id-type="pmid">17003360</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>El Achhab</surname><given-names>Y</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Krempler</surname><given-names>F</given-names></name><name><surname>Weitgasser</surname><given-names>R</given-names></name><etal/></person-group><article-title>TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis</article-title><source>J Mol Med (Berl)</source><year>2007</year><volume>85</volume><issue>7</issue><fpage>777</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">17476472</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandak</surname><given-names>GR</given-names></name><name><surname>Janipalli</surname><given-names>CS</given-names></name><name><surname>Bhaskar</surname><given-names>S</given-names></name><name><surname>Kulkarni</surname><given-names>SR</given-names></name><name><surname>Mohankrishna</surname><given-names>P</given-names></name><etal/></person-group><article-title>Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">17093941</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>S</given-names></name><name><surname>Sivani</surname><given-names>S</given-names></name><name><surname>Sudarsanam</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of single nucleotide polymorphism C825T in the GNB3 gene with the development of type 2 diabetes of the South Indian population</article-title><source>Int J Pharma Sci Res</source><year>2012</year><volume>3</volume><issue>1</issue><fpage>249</fpage><lpage>325</lpage></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>TJ</given-names></name><name><surname>Jiang</surname><given-names>YD</given-names></name><etal/></person-group><article-title>Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><issue>10</issue><fpage>2631</fpage><lpage>2637</lpage><pub-id pub-id-type="pmid">17579206</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavali</surname><given-names>S</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Tabassum</surname><given-names>R</given-names></name><etal/></person-group><article-title>Association of variants in genes involved in pancreatic &#x003b2;-cell development and function with type 2 diabetes in North Indians</article-title><source>J Hum Genet</source><year>2011</year><volume>56</volume><issue>10</issue><fpage>695</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">21814221</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cincia</surname><given-names>C</given-names></name><name><surname>Fusco</surname><given-names>DD</given-names></name><name><surname>Cacciotti</surname><given-names>L</given-names></name><name><surname>Morganti</surname><given-names>R</given-names></name><name><surname>D&#x02019;Amato</surname><given-names>C</given-names></name><name><surname>Novelli</surname><given-names>G</given-names></name><etal/></person-group><article-title>TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy</article-title><source>Acta Diabetol</source><year>2012</year><volume>50</volume><issue>5</issue><fpage>789</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">22843023</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Xavier</surname><given-names>G</given-names></name><name><surname>Loder</surname><given-names>MK</given-names></name><name><surname>McDonald</surname><given-names>A</given-names></name><name><surname>Tarasov</surname><given-names>AI</given-names></name><name><surname>Carzaniga</surname><given-names>R</given-names></name><name><surname>Kronenberger</surname><given-names>K</given-names></name></person-group><article-title>TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells</article-title><source>Diabetes</source><year>2009</year><volume>58</volume><issue>4</issue><fpage>894</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">19168596</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daimon</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Toriyama</surname><given-names>S</given-names></name><name><surname>Emi</surname><given-names>M</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>374</volume><issue>3</issue><fpage>576</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">18656447</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damcott</surname><given-names>CM</given-names></name><name><surname>Pollin</surname><given-names>TI</given-names></name><name><surname>Reinhard</surname><given-names>LJ</given-names></name><name><surname>Ott</surname><given-names>SH</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2654</fpage><lpage>2659</lpage><pub-id pub-id-type="pmid">16936218</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doria</surname><given-names>A</given-names></name><name><surname>Patti</surname><given-names>ME</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name></person-group><article-title>The emerging genetic architecture of type 2 diabetes</article-title><source>Cell Metab</source><year>2008</year><volume>8</volume><issue>3</issue><fpage>186</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">18762020</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duval</surname><given-names>A</given-names></name><name><surname>Busson-Leconiat</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>R</given-names></name><name><surname>Hamelin</surname><given-names>R</given-names></name></person-group><article-title>Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3</article-title><source>Cytogenet Cell Genet</source><year>2000</year><volume>88</volume><fpage>264</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">10828605</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Agapakis</surname><given-names>CM</given-names></name><name><surname>Burtt</surname><given-names>NP</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Rastam</surname><given-names>L</given-names></name><etal/></person-group><article-title>Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people</article-title><source>Diabetes</source><year>2005</year><volume>54</volume><fpage>1884</fpage><lpage>1891</lpage><pub-id pub-id-type="pmid">15919813</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Dabelea</surname><given-names>D</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Type 2 diabetes&#x02013;associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the diabetes prevention program</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><issue>2</issue><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">17259403</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelernter</surname><given-names>J</given-names></name><name><surname>Kruger</surname><given-names>S</given-names></name><name><surname>Pakstis</surname><given-names>AJ</given-names></name><name><surname>Pacholczyk</surname><given-names>T</given-names></name><name><surname>Sparkes</surname><given-names>RS</given-names></name><name><surname>Kidd</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16</article-title><source>Genomics</source><year>1993</year><volume>18</volume><fpage>690</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">7905857</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>R</given-names></name><name><surname>Marzotti</surname><given-names>S</given-names></name><name><surname>Berardelli</surname><given-names>R</given-names></name><name><surname>Karamouzis</surname><given-names>I</given-names></name><name><surname>Brozzetti</surname><given-names>A</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>V</given-names></name><etal/></person-group><article-title>BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison&#x02019;s disease</article-title><source>Clin Endocrinol (Oxf)</source><year>2012</year><volume>77</volume><issue>6</issue><fpage>863</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">22587831</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gjesing</surname><given-names>AP</given-names></name><name><surname>Kjems</surname><given-names>LL</given-names></name><name><surname>Vestmar</surname><given-names>MA</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Deacon</surname><given-names>CF</given-names></name></person-group><article-title>Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test</article-title><source>Diabetologia</source><year>2011</year><volume>54</volume><issue>1</issue><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">20957343</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloyn</surname><given-names>AL</given-names></name><name><surname>Weedon</surname><given-names>MN</given-names></name><name><surname>Owen</surname><given-names>KR</given-names></name><name><surname>Turner</surname><given-names>MJ</given-names></name><name><surname>Knight</surname><given-names>BA</given-names></name><name><surname>Hitman</surname><given-names>G</given-names></name><etal/></person-group><article-title>Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>568</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">12540637</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>SF</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Reynisdottir</surname><given-names>I</given-names></name><name><surname>Benediktsson</surname><given-names>R</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><name><surname>Sainz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>320</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">16415884</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Minton</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><issue>9</issue><fpage>2640</fpage><lpage>2644</lpage><pub-id pub-id-type="pmid">16936215</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinan</surname><given-names>KJ</given-names></name></person-group><article-title>Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe</article-title><source>Biochem Genet</source><year>2012</year><volume>50</volume><issue>3&#x02013;4</issue><fpage>159</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">21898192</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghvirdizadeh</surname><given-names>P</given-names></name><name><surname>Mohamed</surname><given-names>Z</given-names></name><name><surname>Abdullah</surname><given-names>NA</given-names></name><name><surname>Haghvirdizadeh</surname><given-names>P</given-names></name><name><surname>Haerian</surname><given-names>MS</given-names></name><name><surname>Haerian</surname><given-names>BS</given-names></name></person-group><article-title>KCNJ11: genetic polymorphisms and risk of diabetes mellitus</article-title><source>J Diabet Res</source><year>2015</year><volume>908152</volume><fpage>9</fpage></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>MK</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name></person-group><article-title>Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders</article-title><source>Pharmacogenom J</source><year>2002</year><volume>2</volume><fpage>217</fpage><lpage>235</lpage></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname><given-names>T</given-names></name><name><surname>Takamura</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><etal/></person-group><article-title>Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications and diabetic therapies among Japanese</article-title><source>Metabolism</source><year>2007</year><volume>56</volume><issue>1</issue><fpage>44</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">17161225</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><name><surname>Kaku</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name></person-group><article-title>Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>980</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">17340123</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurowitz</surname><given-names>EH</given-names></name><name><surname>Melnyk</surname><given-names>JM</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Kouros-Mehr</surname><given-names>H</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Shizuya</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes</article-title><source>DNA Res</source><year>2000</year><volume>7</volume><issue>2</issue><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">10819326</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>AB</given-names></name><name><surname>Batterham</surname><given-names>M</given-names></name><name><surname>Samocha-Bonet</surname><given-names>D</given-names></name><name><surname>Tonks</surname><given-names>K</given-names></name><name><surname>Greenfield</surname><given-names>JR</given-names></name><name><surname>Campbell</surname><given-names>LV</given-names></name></person-group><article-title>Segregation of a latent high adiposity phenotype in families with a history of type 2 diabetes mellitus implicates rare obesity-susceptibility genetic variants with large effects in diabetes-related obesity</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e70435</fpage><pub-id pub-id-type="pmid">23950934</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyothi</surname><given-names>KU</given-names></name><name><surname>Jayaraj</surname><given-names>M</given-names></name><name><surname>Subburaj</surname><given-names>KS</given-names></name><name><surname>Prasad</surname><given-names>KJ</given-names></name><name><surname>Kumuda</surname><given-names>I</given-names></name><name><surname>Lakshmi</surname><given-names>V</given-names></name></person-group><article-title>Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>4</issue><fpage>e60212</fpage><pub-id pub-id-type="pmid">23577093</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaveeshwar</surname><given-names>SA</given-names></name><name><surname>Cornwall</surname><given-names>J</given-names></name></person-group><article-title>The current state of diabetes mellitus in India</article-title><source>Aust Med J</source><year>2014</year><volume>7</volume><issue>1</issue><fpage>45</fpage><lpage>48</lpage></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshavarz</surname><given-names>P</given-names></name><name><surname>Habibipour</surname><given-names>R</given-names></name><name><surname>Ghasemi</surname><given-names>M</given-names></name><name><surname>Kazemnezhad</surname><given-names>E</given-names></name><name><surname>Alizadeh</surname><given-names>M</given-names></name><name><surname>Omami</surname><given-names>MH</given-names></name></person-group><article-title>Lack of genetic susceptibility of KCNJ11 E23&#x000a0;K polymorphism with risk of type 2 diabetes in an Iranian population</article-title><source>Endocr Res</source><year>2014</year><volume>39</volume><issue>3</issue><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">24460047</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiani</surname><given-names>JG</given-names></name><name><surname>Saeed</surname><given-names>M</given-names></name><name><surname>Parvez</surname><given-names>SH</given-names></name><name><surname>Frossard</surname><given-names>PM</given-names></name></person-group><article-title>Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes</article-title><source>Neuroendocrinol Lett</source><year>2005</year><volume>26</volume><issue>2</issue><fpage>87</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">15855877</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Hahn</surname><given-names>MK</given-names></name><name><surname>Joung</surname><given-names>Y</given-names></name><name><surname>Anderson</surname><given-names>SL</given-names></name><name><surname>Steele</surname><given-names>AH</given-names></name><name><surname>Mazei-Robinson</surname><given-names>MS</given-names></name><etal/></person-group><article-title>A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><issue>50</issue><fpage>19164</fpage><lpage>19169</lpage><pub-id pub-id-type="pmid">17146058</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Cho</surname><given-names>YM</given-names></name><name><surname>Park</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Polymorphisms of KCNJ11 (Kir6.2 gene) are associated with type 2 diabetes and hypertension in the Korean population</article-title><source>Diabet Med</source><year>2007</year><volume>24</volume><issue>2</issue><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">17257281</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ksiazek</surname><given-names>P</given-names></name><name><surname>Buraczynska</surname><given-names>K</given-names></name><name><surname>Buraczynska</surname><given-names>M</given-names></name></person-group><article-title>Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes</article-title><source>Kidney Blood Press Res</source><year>2006</year><volume>29</volume><fpage>338</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">17124432</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasram</surname><given-names>K</given-names></name><name><surname>Ben Halim</surname><given-names>N</given-names></name><name><surname>Hsouna</surname><given-names>S</given-names></name><name><surname>Kefi</surname><given-names>R</given-names></name><name><surname>Arfa</surname><given-names>I</given-names></name><name><surname>Ghazouani</surname><given-names>W</given-names></name><etal/></person-group><article-title>Evidence for Association of the E23K Variant of KCNJ11 Gene with Type 2 Diabetes in Tunisian Population: Population-Based Study and Meta-Analysis</article-title><source>Biomed Res Int</source><year>2014</year><volume>2014</volume><fpage>265</fpage><lpage>274</lpage></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>YW</given-names></name><name><surname>Feng</surname><given-names>QP</given-names></name><etal/></person-group><article-title>Association analysis of 30 type 2 diabetes candidate genes in Chinese Han population</article-title><source>Acta Acad Med Sin</source><year>2006</year><volume>28</volume><issue>2</issue><fpage>124</fpage><lpage>128</lpage></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>C</given-names></name><name><surname>Greco</surname><given-names>A</given-names></name><name><surname>Fiorentino</surname><given-names>TV</given-names></name><name><surname>Mannino</surname><given-names>GC</given-names></name><name><surname>Hribal</surname><given-names>ML</given-names></name></person-group><article-title>Variants of insulin-signaling inhibitor genes in type 2 diabetes and related metabolic abnormalities</article-title><source>Int J Genom</source><year>2013</year><volume>376454</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Lupi</surname><given-names>R</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes</article-title><source>J Clin Invest</source><year>2007</year><volume>117</volume><issue>8</issue><fpage>2155</fpage><lpage>2163</lpage><pub-id pub-id-type="pmid">17671651</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maniotis</surname><given-names>C</given-names></name><name><surname>Chantziara</surname><given-names>K</given-names></name><name><surname>Kokkoris</surname><given-names>P</given-names></name><name><surname>Papadogiannis</surname><given-names>D</given-names></name><name><surname>Andreou</surname><given-names>C</given-names></name><name><surname>Tsioufis</surname><given-names>C</given-names></name><etal/></person-group><article-title>The AGT and the GNB3 polymorphisms and insulin resistance in prehypertension</article-title><source>Hormones (Athens)</source><year>2014</year><volume>13</volume><issue>1</issue><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">24722130</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquezine</surname><given-names>GF</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Sousa</surname><given-names>AG</given-names></name><name><surname>Mill</surname><given-names>JG</given-names></name><name><surname>Hueb</surname><given-names>WA</given-names></name><etal/></person-group><article-title>TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>106</fpage><pub-id pub-id-type="pmid">19055834</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>A</given-names></name><name><surname>Ochoa</surname><given-names>MC</given-names></name><name><surname>Sanchez-Villegas</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>JA</given-names></name><name><surname>Martinez-Gonzalez</surname><given-names>MA</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Vedder</surname><given-names>H</given-names></name></person-group><article-title>Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity</article-title><source>BMC Med Genet</source><year>2006</year><volume>7</volume><fpage>50</fpage><pub-id pub-id-type="pmid">16725041</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McTaggart</surname><given-names>JS</given-names></name><name><surname>Clark</surname><given-names>RH</given-names></name><name><surname>Ashcroft</surname><given-names>FM</given-names></name></person-group><article-title>The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet</article-title><source>J Physiol</source><year>2010</year><volume>588</volume><issue>17</issue><fpage>3201</fpage><lpage>3209</lpage><pub-id pub-id-type="pmid">20519313</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Horikawa</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects</article-title><source>J Hum Genet</source><year>2008</year><volume>53</volume><issue>2</issue><fpage>174</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">18097733</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanfa</surname><given-names>D</given-names></name><name><surname>Sobngwi</surname><given-names>E</given-names></name><name><surname>Atogho-Tiedeu</surname><given-names>B</given-names></name><name><surname>Noubiap</surname><given-names>JJ</given-names></name><name><surname>Donfack</surname><given-names>OS</given-names></name><name><surname>Mofo</surname><given-names>EP</given-names></name><etal/></person-group><article-title>Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study</article-title><source>Clin Transl Med</source><year>2015</year><volume>4</volume><fpage>17</fpage><pub-id pub-id-type="pmid">25995831</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neubauer</surname><given-names>B</given-names></name><name><surname>Christensen</surname><given-names>NJ</given-names></name></person-group><article-title>Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long-term diabetics</article-title><source>Diabetes</source><year>1976</year><volume>25</volume><issue>1</issue><fpage>6</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">1245267</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>MC</given-names></name><name><surname>Tam</surname><given-names>CHT</given-names></name><name><surname>Lam</surname><given-names>VK</given-names></name><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Ma</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>3733</fpage><lpage>3737</lpage><pub-id pub-id-type="pmid">17609304</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikitin</surname><given-names>AG</given-names></name><name><surname>Potapov</surname><given-names>VA</given-names></name><name><surname>Brovkin</surname><given-names>AN</given-names></name><name><surname>Lavrikova</surname><given-names>EIu</given-names></name><name><surname>Hodyrev</surname><given-names>DS</given-names></name><name><surname>Shamkhalova</surname><given-names>MSh</given-names></name><etal/></person-group><article-title>Association of the polymorphisms of the FTO, KCNJ11, SLC30A8 and CDKN2B genes with type 2 diabetes</article-title><source>Mol Biol (Mosk)</source><year>2015</year><volume>49</volume><issue>1</issue><fpage>119</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">25916116</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacholczyk</surname><given-names>T</given-names></name><name><surname>Blakely</surname><given-names>RD</given-names></name><name><surname>Amara</surname><given-names>SG</given-names></name></person-group><article-title>Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter</article-title><source>Nature</source><year>1991</year><volume>350</volume><issue>6316</issue><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">2008212</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parra</surname><given-names>EJ</given-names></name><name><surname>Hoggart</surname><given-names>CJ</given-names></name><name><surname>Bonilla</surname><given-names>C</given-names></name><name><surname>Dios</surname><given-names>S</given-names></name><name><surname>Norris</surname><given-names>JM</given-names></name><name><surname>Marshall</surname><given-names>JA</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Relation of type 2 diabetes to individual admixture and candidate gene polymorphisms in the Hispanic American population of San Luis Valley, Colorado</article-title><source>J Med Genet</source><year>2004</year><volume>41</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14729816</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pemberton</surname><given-names>TJ</given-names></name><name><surname>Mehta</surname><given-names>NU</given-names></name><name><surname>Witonsky</surname><given-names>D</given-names></name><name><surname>Di</surname><given-names>RA</given-names></name><name><surname>Allayee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prevalence of common disease-associated variants in Asian Indians</article-title><source>BMC Genet</source><year>2008</year><volume>9</volume><fpage>13</fpage><pub-id pub-id-type="pmid">18248681</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollex</surname><given-names>RL</given-names></name><name><surname>Hanley</surname><given-names>AJ</given-names></name><name><surname>Zinman</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>SB</given-names></name><name><surname>Khan</surname><given-names>HM</given-names></name><name><surname>Hegele</surname><given-names>RA</given-names></name></person-group><article-title>Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations</article-title><source>Atherosclerosis</source><year>2006</year><volume>184</volume><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">15869758</pub-id></element-citation></ref><ref id="CR63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>L</given-names></name><name><surname>Na</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Quantitative assessment of the effect of KCNJ11 gene polymorphism on the risk of type 2 diabetes</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>e93961</fpage><pub-id pub-id-type="pmid">24710510</pub-id></element-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastegari</surname><given-names>A</given-names></name><name><surname>Rabbani</surname><given-names>M</given-names></name><name><surname>Sadeghi</surname><given-names>HM</given-names></name><name><surname>Imani</surname><given-names>EF</given-names></name><name><surname>Hasanzadeh</surname><given-names>A</given-names></name><name><surname>Moazen</surname><given-names>F</given-names></name></person-group><article-title>Association of KCNJ11 (E23K) gene polymorphism with susceptibility to type 2 diabetes in Iranian patients</article-title><source>Adv Biomed Res</source><year>2015</year><volume>4</volume><fpage>1</fpage><pub-id pub-id-type="pmid">25625107</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raza</surname><given-names>ST</given-names></name><name><surname>Abbas</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>A</given-names></name><name><surname>Ahmed</surname><given-names>F</given-names></name><name><surname>Zaidi</surname><given-names>ZH</given-names></name><name><surname>Mahdi</surname><given-names>F</given-names></name></person-group><article-title>Association of glutathione-S-transferase (GSTM1 and GSTT1) and FTO gene polymorphisms with type 2 diabetes mellitus cases in Northern India</article-title><source>Balkan J Med Genet</source><year>2014</year><volume>17</volume><issue>1</issue><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">25741215</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizvi</surname><given-names>S</given-names></name><name><surname>Raza</surname><given-names>ST</given-names></name><name><surname>Mahdi</surname><given-names>F</given-names></name></person-group><article-title>Association of genetic variants with diabetic nephropathy</article-title><source>World J Diabet</source><year>2014</year><volume>5</volume><issue>6</issue><fpage>809</fpage><lpage>816</lpage></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosmond</surname><given-names>R</given-names></name><name><surname>Holm</surname><given-names>GJ</given-names></name></person-group><article-title>A 5-year follow-up study of 3 polymorphisms in the human glucocorticoid receptor gene in relation to obesity, hypertension, and diabetes</article-title><source>Cardiometab Syndr</source><year>2008</year><volume>3</volume><issue>3</issue><fpage>132</fpage><lpage>135</lpage></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roussel</surname><given-names>R</given-names></name><name><surname>Reis</surname><given-names>AF</given-names></name><name><surname>Dubois-Laforgue</surname><given-names>D</given-names></name><name><surname>Bellann&#x000e9;-Chantelot</surname><given-names>C</given-names></name><name><surname>Timsit</surname><given-names>J</given-names></name><name><surname>Velho</surname><given-names>G</given-names></name></person-group><article-title>The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus</article-title><source>Clin Endocrinol (Oxf)</source><year>2003</year><volume>59</volume><issue>2</issue><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">12864802</pub-id></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Keshavarz</surname><given-names>P</given-names></name><etal/></person-group><article-title>SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population</article-title><source>J Hum Genet</source><year>2007</year><volume>52</volume><issue>10</issue><fpage>781</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">17823772</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sale</surname><given-names>MM</given-names></name><name><surname>Smith</surname><given-names>SG</given-names></name><name><surname>Mychaleckyj</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><issue>10</issue><fpage>2638</fpage><lpage>2642</lpage><pub-id pub-id-type="pmid">17601994</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>SA</given-names></name><name><surname>Tschritter</surname><given-names>O</given-names></name><name><surname>Machicao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><issue>12</issue><fpage>2443</fpage><lpage>2450</lpage><pub-id pub-id-type="pmid">17661009</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>LJ</given-names></name><name><surname>Bonnycastle</surname><given-names>C</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Sprau</surname><given-names>AG</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><etal/></person-group><article-title>Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2649</fpage><lpage>2653</lpage><pub-id pub-id-type="pmid">16936217</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sesti</surname><given-names>G</given-names></name><name><surname>Laratta</surname><given-names>E</given-names></name><name><surname>Cardellini</surname><given-names>M</given-names></name><name><surname>Andreozzi</surname><given-names>F</given-names></name><name><surname>Del Guerra</surname><given-names>S</given-names></name><name><surname>Irace</surname><given-names>C</given-names></name><etal/></person-group><article-title>The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5&#x02032;-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>2334</fpage><lpage>2339</lpage><pub-id pub-id-type="pmid">16595597</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>JR</given-names></name><name><surname>Flattem</surname><given-names>NL</given-names></name><name><surname>Jordan</surname><given-names>J</given-names></name><name><surname>Jacob</surname><given-names>G</given-names></name><name><surname>Black</surname><given-names>BK</given-names></name><name><surname>Biaggioni</surname><given-names>I</given-names></name><etal/></person-group><article-title>Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>8</issue><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">10684912</pub-id></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shokouhi</surname><given-names>S</given-names></name><name><surname>Delpisheh</surname><given-names>A</given-names></name><name><surname>Haghani</surname><given-names>K</given-names></name><name><surname>Mahdizadeh</surname><given-names>M</given-names></name><name><surname>Bakhtiyari</surname><given-names>S</given-names></name></person-group><article-title>Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group</article-title><source>Clin Lab</source><year>2014</year><volume>60</volume><issue>8</issue><fpage>1269</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">25185411</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Sauter</surname><given-names>NS</given-names></name><name><surname>Schulthess</surname><given-names>FT</given-names></name><name><surname>Matveyenko</surname><given-names>AV</given-names></name><name><surname>Oberholzer</surname><given-names>J</given-names></name><name><surname>Maedler</surname><given-names>K</given-names></name></person-group><article-title>Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><issue>3</issue><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">18071026</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siffert</surname><given-names>W</given-names></name></person-group><article-title>G protein polymorphisms in hypertension, atherosclerosis, and diabetes</article-title><source>Annu Rev Med</source><year>2005</year><volume>56</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">15660499</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tellioglu</surname><given-names>T</given-names></name><name><surname>Robertson</surname><given-names>D</given-names></name></person-group><article-title>Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications</article-title><source>Expert Rev Mol Med</source><year>2001</year><volume>29</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association between TCF7L2 gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis</article-title><source>BMC Med Genet</source><year>2009</year><volume>10</volume><fpage>15</fpage><pub-id pub-id-type="pmid">19228405</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trementino</surname><given-names>L</given-names></name><name><surname>Appolloni</surname><given-names>G</given-names></name><name><surname>Concettoni</surname><given-names>C</given-names></name><name><surname>Cardinaletti</surname><given-names>M</given-names></name><name><surname>Boscaro</surname><given-names>M</given-names></name><name><surname>Arnaldi</surname><given-names>G</given-names></name></person-group><article-title>Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing&#x02019;s syndrome</article-title><source>Eur J Endocrinol</source><year>2012</year><volume>166</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">22048965</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Schwarz</surname><given-names>PE</given-names></name><name><surname>Bosque-Plata</surname><given-names>LD</given-names></name><name><surname>Hayes</surname><given-names>MG</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><etal/></person-group><article-title>Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses</article-title><source>Mol Genet Metab</source><year>2006</year><volume>89</volume><fpage>174</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">16837224</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Raalte</surname><given-names>DH</given-names></name><name><surname>van Leeuwen</surname><given-names>N</given-names></name><name><surname>Simonis-Bik</surname><given-names>AM</given-names></name><name><surname>Nijpels</surname><given-names>G</given-names></name><name><surname>van Haeften</surname><given-names>TW</given-names></name><name><surname>Schafer</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men</article-title><source>Diabet Med</source><year>2012</year><volume>29</volume><issue>8</issue><fpage>e211</fpage><lpage>e216</lpage><pub-id pub-id-type="pmid">22507373</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Shiri-Sverdlov</surname><given-names>R</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>van Haeften</surname><given-names>TW</given-names></name><etal/></person-group><article-title>Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">17031610</pub-id></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis</article-title><source>Braz J Med Biol Res</source><year>2013</year><volume>46</volume><issue>4</issue><fpage>382</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">23579632</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>JU</given-names></name><name><surname>Hitman</surname><given-names>GA</given-names></name><name><surname>Kopelman</surname><given-names>PG</given-names></name></person-group><article-title>An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women</article-title><source>J Mol Endocrinol</source><year>1992</year><volume>9</volume><issue>3</issue><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">1362060</pub-id></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Segawa</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Kameyama</surname><given-names>T</given-names></name><etal/></person-group><article-title>Assessment of genetic factors for type 2 diabetes mellitus</article-title><source>Int J Mol Med</source><year>2006</year><volume>18</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">16820938</pub-id></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>H</given-names></name><name><surname>Pang</surname><given-names>C</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name></person-group><article-title>Association of the rs11196218 polymorphism in TCF7L2 with type 2 diabetes mellitus in Asian population</article-title><source>Meta Gene</source><year>2014</year><volume>2</volume><fpage>332</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">25606417</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2645</fpage><lpage>2648</lpage><pub-id pub-id-type="pmid">16936216</pub-id></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population</article-title><source>J Hum Genet</source><year>2009</year><volume>54</volume><issue>7</issue><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">19498446</pub-id></element-citation></ref><ref id="CR91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zychma</surname><given-names>MJ</given-names></name><name><surname>Zukowska-Szczechowska</surname><given-names>E</given-names></name><name><surname>Ossowska-Szymkowicz</surname><given-names>I</given-names></name><etal/></person-group><article-title>G-protein &#x003b2;3 subunit C825T variant, nephropathy and hypertension in patients with type 2 (non-insulin-dependent) diabetes mellitus</article-title><source>Am J Nephrol</source><year>2000</year><volume>20</volume><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">10970984</pub-id></element-citation></ref></ref-list></back></article>